Skip to main content
Open Access Publications from the University of California

Exploiting the promiscuity of imatinib

  • Author(s): Lee, SJ
  • Wang, JYJ
  • et al.

Published Web Location

The protein kinase inhibitor imatinib, also known as Gleevec, has been a notable success in treating chronic myelogenous leukemia. A recent paper in BMC Structural Biology reports a 1.75 Å crystal structure of imatinib bound to the oxidoreductase NQO2 and reveals insights into the binding specificity and the off-target effects of the inhibitor. © 2009 BioMed Central Ltd.

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Main Content
Current View